ML11229A081: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(StriderTol Bot change)
 
(2 intermediate revisions by the same user not shown)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:* File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM *
{{#Wiki_filter:NIA-089
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'  
* File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM
*
* DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
* EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'  
* EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'
*
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.
* ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.  
* IPLUME - dispersion code option MIIPLUME001 2
*
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7
* IPLUME - dispersion code option MIIPLUME001 2  
* IPRINT - amount of output desired MIIPRINT001 0
*
* NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7 *
* IPRINT - amount of output desired MIIPRINT001 0  
*
* POPFLG - is population uniform or defined by Site Data File.
* POPFLG - is population uniform or defined by Site Data File.
PDPOPFLG001 FILE  
PDPOPFLG001 FILE
*
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.
* ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE. MIORGDEF002  
MIORGDEF002 'A-RED MARR' .TRUE.
'A-RED MARR' .TRUE. MIORGDEF003 A-LUNGS .TRUE.
MIORGDEF003 A-LUNGS               .TRUE.
MIORGDEF004 A-THYROIDH .TRUE.
MIORGDEF004 A-THYROIDH .TRUE.
MIORGDEF005 A-STOMACH .TRUE.
MIORGDEF005 A-STOMACH .TRUE.
MIORGDEF006  
MIORGDEF006 'A-LOWER LI' .FALSE.
'A-LOWER LI' .FALSE. MIORGDEF007 L-EDEWBODY .TRUE.
MIORGDEF007 L-EDEWBODY .TRUE.
MIORGDEF008  
MIORGDEF008 'L-RED MARR' .TRUE.
'L-RED MARR' .TRUE. MIORGDEF009  
MIORGDEF009 'L-BONE SUR' .TRUE.
'L-BONE SUR' .TRUE.
MIORGDEF010 L-BREAST             .TRUE.
MIORGDEF010 L-BREAST .TRUE. MIORGDEF011 L-LUNGS .TRUE.
MIORGDEF011 L-LUNGS               .TRUE.
MIORGDEF012 L-THYROID .TRUE.
MIORGDEF012 L-THYROID             .TRUE.
MIORGDEF013  
MIORGDEF013 'L-LOWER LI' .TRUE.
'L-LOWER LI' .TRUE. MIORGDEF014  
MIORGDEF014 'L-BLAD WAL' .TRUE.
'L-BLAD WAL' .TRUE. MIORGDEF015 L-LIVER .FALSE.
MIORGDEF015 L-LIVER .FALSE.
MIORGDEF016 L-THYROIDH .TRUE.  
MIORGDEF016 L-THYROIDH           .TRUE.
*
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.
* RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.  
* OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.
*
 
* OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE. *
NIA-089
* CSFACT - Cloudshine shielding factor SECSFACT001  
* CSFACT - Cloudshine shielding factor SECSFACT001 1.
: 1. SECSFACT002 0.75 SECSFACT003 0.6  
SECSFACT002 0.75 SECSFACT003 0.6
*
* PROTIN - Inhalation protection factor SEPROTIN001 1.
* PROTIN - Inhalation protection factor SEPROTIN001  
SEPROTIN002 0.41 SEPROTIN003 0.33
: 1. SEPROTIN002 0.41 SEPROTIN003 0.33  
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4
*
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33
* BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4 *
* GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2
* SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC 003 0.33 *
* RESCON - Initial value for emergency-phase resuspension concentration factor.
* GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2  
SERESCON001 1.E-4
*
* RESCON - Initial value for emergency-phase resuspension concentration factor. SERESCON001 1.E-4 *
* RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.
* RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.
SERESHAF001 1.82E5  
SERESHAF001 1.82E5
*
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
* EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'  
* WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE
*
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00
* WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE *
* LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0
* WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00 *
* ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.
* LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0  
* CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY
*
 
* ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800. *
NIA-089
* CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY
* TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.
*
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)
* TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.  
SRTIMNRM001 86400.
*
* TIMNRM - Normal Relocation Time (Seconds from Plume Arrival) SRTIMNRM001 86400. *
* DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)
* DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)
SRDOSHOT001 0.5  
SRDOSHOT001 0.5
*
* DOSNRM - Normal Relocation Dose Threshold (Sieverts)
* DOSNRM - Normal Relocation Dose Threshold (Sieverts)
SRDOSNRM001 0.25  
SRDOSNRM001 0.25
*
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2
* NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2 *
* ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)
* ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)
EFATAGRP001  
EFATAGRP001 'A-RED MARR' 3.8             5.0     1.5 EFATAGRP002 A-LUNGS             10.0 7.0         5.0
'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0  
* NUMEIN - Number of Early Injury Effects EINUMEIN001 7
*
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.
* NUMEIN - Number of Early Injury Effects EINUMEIN001 7  
EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1.                     .5       2.     3.
*
EINJUGRP002 DIARRHEA           A-STOMACH 1.             1. 3.       2.5 EINJUGRP003 PNEUMONITIS A-LUNGS                 1.       5. 10.     7.
* ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor. EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH  
EINJUGRP004 'SKIN ERYTHEMA'             A-SKIN 1.       3. 6.       5.
: 1. .5 2. 3. EINJUGRP002 DIARRHEA A-STOMACH  
EINJUGRP005 TRANSEPIDERMAL               A-SKIN 1.       10. 20.     5.
: 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS  
EINJUGRP006 THYROIDITIS A-THYROIDH 1.                     40. 240. 2.
: 1. 5. 10. 7. EINJUGRP004 'SKIN ERYTHEMA' A-SKIN  
EINJUGRP007 HYPOTHYROIDISM               A-THYROIDH 1.         2.       60. 1.3
: 1. 3. 6. 5. EINJUGRP005 TRANSEPIDERMAL A-SKIN  
* NUMACA - number of latent cancer effects LCNUMACA001 7
: 1. 10. 20. 5. EINJUGRP006 THYROIDITIS A-THYROIDH  
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0
: 1. 40. 240. 2. EINJUGRP007 HYPOTHYROIDISM A-THYROIDH  
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
: 1. 2. 60. 1.3 *
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA           'L-RED MARR' 1.0         1.0 0.0     9.70E-3 0.0   2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0               1.0     0.0 9.00E-4 0.0     2.0 LCANCERS003 BREAST L-BREAST             1.0     1.0     0.0 5.40E-3 1.7E-2 1.0
* NUMACA - number of latent cancer effects LCNUMACA001 7 *
 
* ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0 *
NIA-089 LCANCERS004 LUNG L-LUNGS               1.0     1.0   0.0 1.55E-2 0.0     2.0 LCANCERS005 THYROID           L-THYROIDH     1.0   1.0 0.0     7.20E-4 7.2E-3 1.0 LCANCERS006 GI         'L-LOWER LI' 1.0       1.0   0.0 3.36E-2 0.0     2.0 LCANCERS007 OTHER L-EDEWBODY 1.0               1.0   0.0 2.76E-2 0.0     2.0
* DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2  
* NUM1=0 TYPE1NUMBER 0
*
* NUM1 - Number of results of type 1 TYPE1NUMBER 4
* ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA  
* NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL'           1       15   NONE TYPE1OUT002 'CAN FAT/TOTAL'           1       15   NONE TYPE1OUT003 'CAN FAT/TOTAL'           1       11   NONE TYPE1OUT004 'ERL FAT/TOTAL'           1       11   NONE
'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE  
* NUM2=0 TYPE2NUMBER 0
'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0  
* NUM3=0 TYPE3NUMBER 0
*
* NUM4=0 TYPE4NUMBER 0
* NUM1=0 TYPE1NUMBER 0  
* NUM4 - Number of results of type 4 TYPE4NUMBER 3
*
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1         'ERL FAT/TOTAL'         NONE TYPE4OUT002 2         'ERL FAT/TOTAL'         NONE TYPE4OUT003 3         'ERL FAT/TOTAL'         NONE
* NUM1 - Number of results of type 1 TYPE1NUMBER 4  
* NUM5 =0 TYPE5NUMBER 0
*
* NUM5 - Number of results of type 5 TYPE5NUMBER 1
* NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE *
* NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1               15     NONE
* NUM2=0 TYPE2NUMBER 0  
* NUM6 =0 TYPE6NUMBER 0
*
* NUM7=0 TYPE7NUMBER 0
* NUM3=0 TYPE3NUMBER 0  
 
*
NIA-089
* NUM4=0 TYPE4NUMBER 0 *
* NUM8=0 TYPE8NUMBER 0
* NUM4 - Number of results of type 4 TYPE4NUMBER 3 *
* NUM8 - Number of results of type 8 TYPE8NUMBER 2
* I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE  
* NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL'           1     3       NONE TYPE8OUT002 'CAN FAT/TOTAL'           1     11       NONE
*
* NUMA=0 TYPEANUMBER 0
* NUM5 =0 TYPE5NUMBER 0 *
* NUMB =0 TYPEBNUMBER 0
* NUM5 - Number of results of type 5 TYPE5NUMBER 1 *
* NUMB - Number of results of type B TYPEBNUMBER 20
* NAME5, I1DIS5, CCDF 5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE *
* NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1             1     NONE TYPEBOUT002 L-EDEWBODY 2             1     NONE TYPEBOUT003 L-EDEWBODY 3             1     NONE TYPEBOUT004 L-EDEWBODY 4             1     NONE TYPEBOUT005 L-EDEWBODY 5             1     NONE TYPEBOUT006 L-EDEWBODY 6             1     NONE TYPEBOUT007 L-EDEWBODY 7             1     NONE TYPEBOUT008 L-EDEWBODY 8             1     NONE TYPEBOUT009 L-EDEWBODY 9             1     NONE TYPEBOUT010 L-EDEWBODY 10             1     NONE TYPEBOUT011 L-EDEWBODY 1             9     NONE TYPEBOUT012 L-EDEWBODY 2             9     NONE TYPEBOUT013 L-EDEWBODY 3             9     NONE TYPEBOUT014 L-EDEWBODY 4             9     NONE TYPEBOUT015 L-EDEWBODY 5             9     NONE TYPEBOUT016 L-EDEWBODY 6             9     NONE TYPEBOUT017 L-EDEWBODY 7             9     NONE TYPEBOUT018 L-EDEWBODY 8             9     NONE TYPEBOUT019 L-EDEWBODY 9             9     NONE TYPEBOUT020 L-EDEWBODY 10             9     NONE
* NUM6 =0 TYPE6NUMBER 0 *
* NUMC=0 TYPECNUMBER 0
* NUM7=0 TYPE7NUMBER 0
* NUMD = 0 TYPEDNUMBER 0
*
 
* NUM8=0 TYPE8NUMBER 0  
NIA-089
*
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT
* NUM8 - Number of results of type 8 TYPE8NUMBER 2 *
* KIMODL, KI model EZKIMODL001 NOKI
* NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE *
* EFFACY, KI Ingestion EZEFFACY001 0.
* NUMA=0 TYPEANUMBER 0  
* POPFRAC, KI Ingestion EZPOPFRC001 0.
*
.}}
* NUMB =0 TYPEBNUMBER 0 *
* NUMB - Number of results of type B TYPEBNUMBER 20 *
* NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE *
* NUMC=0 TYPECNUMBER 0  
*
* NUMD = 0 TYPEDNUMBER 0 *
* DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT *
* KIMODL, KI model EZKIMODL001 NOKI *
* EFFACY, KI Ingestion EZEFFACY001  
: 0. *
* POPFRAC, KI Ingestion EZPOPFRC001  
: 0. .}}

Latest revision as of 18:02, 10 March 2020

Lr Hearing - NIA-089
ML11229A081
Person / Time
Site: Indian Point  Entergy icon.png
Issue date: 10/29/2009
From:
Sandia
To:
Office of Nuclear Reactor Regulation
References
NIA-089
Download: ML11229A081 (6)
v • d • e


Text

NIA-089

  • File created using WinMACCS version 3.4.5 10/29/2009 5:21:34 PM
  • DCF_FILE - Identifies the DCF file to be used for the MACCS calculation DCF_FILE001 'f:\NBixler\WinMACCS Projects\IndianPointPalla\Data\DOSDATA.INP'
  • EANAM1 - Identifies the EARLY calculation MIEANAM1001 'EARLY.IN, IPEC INPUT FROM THE EVACUATION TIME ESTIMATES'
  • ENDAT2 - control flag allowing execution of ATMOS and EARLY without CHRONC MIENDAT2001 .FALSE.
  • IPLUME - dispersion code option MIIPLUME001 2
  • NUMFIN - number of fine-grid subdivisions used by model MINUMFIN001 7
  • IPRINT - amount of output desired MIIPRINT001 0
  • POPFLG - is population uniform or defined by Site Data File.

PDPOPFLG001 FILE

  • ORGNAM_DOSFAC, ORGFLG_DOSFAC - list of organs to be included in the calculations using DOSFAC DCF file MIORGDEF001 A-SKIN .TRUE.

MIORGDEF002 'A-RED MARR' .TRUE.

MIORGDEF003 A-LUNGS .TRUE.

MIORGDEF004 A-THYROIDH .TRUE.

MIORGDEF005 A-STOMACH .TRUE.

MIORGDEF006 'A-LOWER LI' .FALSE.

MIORGDEF007 L-EDEWBODY .TRUE.

MIORGDEF008 'L-RED MARR' .TRUE.

MIORGDEF009 'L-BONE SUR' .TRUE.

MIORGDEF010 L-BREAST .TRUE.

MIORGDEF011 L-LUNGS .TRUE.

MIORGDEF012 L-THYROID .TRUE.

MIORGDEF013 'L-LOWER LI' .TRUE.

MIORGDEF014 'L-BLAD WAL' .TRUE.

MIORGDEF015 L-LIVER .FALSE.

MIORGDEF016 L-THYROIDH .TRUE.

  • RISCAT - Output relative contribution of each weather category bins MIRISCAT001 .FALSE.
  • OVRRID - Flag indicating if Wind Rose defaults from ATMOS are to be overridden MIOVRRID001 .FALSE.

NIA-089

  • CSFACT - Cloudshine shielding factor SECSFACT001 1.

SECSFACT002 0.75 SECSFACT003 0.6

  • PROTIN - Inhalation protection factor SEPROTIN001 1.

SEPROTIN002 0.41 SEPROTIN003 0.33

  • BRRATE - Breathing rates SEBRRATE001 2.66E-4 SEBRRATE002 2.66E-4 SEBRRATE003 2.66E-4
  • SKPFAC - skin protection factors SESKPFAC001 1.0 SESKPFAC002 0.41 SESKPFAC003 0.33
  • GSHFAC - groundshine shielding factors SEGSHFAC001 0.5 SEGSHFAC002 0.4 SEGSHFAC003 0.2
  • RESCON - Initial value for emergency-phase resuspension concentration factor.

SERESCON001 1.E-4

  • RESHAF - Emergency-phase resuspension concentration coefficient weathering half-life.

SERESHAF001 1.82E5

  • EANAM2 - Name of emergency response scenario EZEANAM2001 'NO EVACUATION, RELOCATION MODELS APPLY EVERYWHE'
  • WTNAME - type of weighting factor to be used in generating weighted sum of results EZWTNAME001 PEOPLE
  • WTFRAC - weighting fraction applied to results of emergency response scenario EZWTFRAC001 1.00
  • LASMOV2 (used for no evacuation), always 0 EZLASMOV001 0
  • ENDEMP - duration of the emergency-phase period, seconds SRENDEMP001 604800.
  • CRIORG - critical organ for relocation decisions during emergency-phase period SRCRIORG001 L-EDEWBODY

NIA-089

  • TIMHOT - hot-spot relocation action time, seconds after plume arrival SRTIMHOT001 43200.
  • TIMNRM - Normal Relocation Time (Seconds from Plume Arrival)

SRTIMNRM001 86400.

  • DOSHOT - Hot-Spot Relocation Dose Threshold (Sieverts)

SRDOSHOT001 0.5

  • DOSNRM - Normal Relocation Dose Threshold (Sieverts)

SRDOSNRM001 0.25

  • NUMEFA - Number of Early Fatality Effects EFNUMEFA001 2
  • ORGNAM2, EFFACA, EFFACB, EFFTHR Early Fatality Effects - target organ, alpha factor and beta factor for hazard function, and threshold dose (Sieverts)

EFATAGRP001 'A-RED MARR' 3.8 5.0 1.5 EFATAGRP002 A-LUNGS 10.0 7.0 5.0

  • NUMEIN - Number of Early Injury Effects EINUMEIN001 7
  • ORGNAM3, EINAME, EISUSC, EITHRE, EIFACA, EIFACB Early Injury Effects - name, target organ, affected population fract, threshold dose, alpha factor, beta factor.

EINJUGRP001 'PRODROMAL VOMIT' A-STOMACH 1. .5 2. 3.

EINJUGRP002 DIARRHEA A-STOMACH 1. 1. 3. 2.5 EINJUGRP003 PNEUMONITIS A-LUNGS 1. 5. 10. 7.

EINJUGRP004 'SKIN ERYTHEMA' A-SKIN 1. 3. 6. 5.

EINJUGRP005 TRANSEPIDERMAL A-SKIN 1. 10. 20. 5.

EINJUGRP006 THYROIDITIS A-THYROIDH 1. 40. 240. 2.

EINJUGRP007 HYPOTHYROIDISM A-THYROIDH 1. 2. 60. 1.3

  • NUMACA - number of latent cancer effects LCNUMACA001 7
  • ACTHRE - dose threshold for linear dose response, Sieverts LCACTHRE001 0.0
  • DDTHRE - dose threshold for applying dose-dependent reduction factor, DDREFA LCDDTHRE001 0.2
  • ACNAME, ORGNAM4, ACSUSC, DOSEFA, DOSEFB, CFRISK, CIRISK, DDREFA - Latent Cancer Effects Parameters LCANCERS001 LEUKEMIA 'L-RED MARR' 1.0 1.0 0.0 9.70E-3 0.0 2.0 LCANCERS002 BONE 'L-BONE SUR' 1.0 1.0 0.0 9.00E-4 0.0 2.0 LCANCERS003 BREAST L-BREAST 1.0 1.0 0.0 5.40E-3 1.7E-2 1.0

NIA-089 LCANCERS004 LUNG L-LUNGS 1.0 1.0 0.0 1.55E-2 0.0 2.0 LCANCERS005 THYROID L-THYROIDH 1.0 1.0 0.0 7.20E-4 7.2E-3 1.0 LCANCERS006 GI 'L-LOWER LI' 1.0 1.0 0.0 3.36E-2 0.0 2.0 LCANCERS007 OTHER L-EDEWBODY 1.0 1.0 0.0 2.76E-2 0.0 2.0

  • NUM1=0 TYPE1NUMBER 0
  • NUM1 - Number of results of type 1 TYPE1NUMBER 4
  • NAME1, I1DIS1, I2DIS1, CCDF1 - Health-Effect Cases TYPE1OUT001 'ERL FAT/TOTAL' 1 15 NONE TYPE1OUT002 'CAN FAT/TOTAL' 1 15 NONE TYPE1OUT003 'CAN FAT/TOTAL' 1 11 NONE TYPE1OUT004 'ERL FAT/TOTAL' 1 11 NONE
  • NUM2=0 TYPE2NUMBER 0
  • NUM3=0 TYPE3NUMBER 0
  • NUM4=0 TYPE4NUMBER 0
  • NUM4 - Number of results of type 4 TYPE4NUMBER 3
  • I1DIS4, NAME4, CCDF4 - Average Individual Risk TYPE4OUT001 1 'ERL FAT/TOTAL' NONE TYPE4OUT002 2 'ERL FAT/TOTAL' NONE TYPE4OUT003 3 'ERL FAT/TOTAL' NONE
  • NUM5 =0 TYPE5NUMBER 0
  • NUM5 - Number of results of type 5 TYPE5NUMBER 1
  • NAME5, I1DIS5, CCDF5 - Population Dose TYPE5OUT001 L-EDEWBODY 1 15 NONE
  • NUM6 =0 TYPE6NUMBER 0
  • NUM7=0 TYPE7NUMBER 0

NIA-089

  • NUM8=0 TYPE8NUMBER 0
  • NUM8 - Number of results of type 8 TYPE8NUMBER 2
  • NAME8, I1DIS8, I2DIS8, CCDF8 - Population-Weighted Risk TYPE8OUT001 'ERL FAT/TOTAL' 1 3 NONE TYPE8OUT002 'CAN FAT/TOTAL' 1 11 NONE
  • NUMA=0 TYPEANUMBER 0
  • NUMB =0 TYPEBNUMBER 0
  • NUMB - Number of results of type B TYPEBNUMBER 20
  • NAMEB, IRAD_B, IANG_B, CCDFB - Peak Dose at an (r, theta) Location TYPEBOUT001 L-EDEWBODY 1 1 NONE TYPEBOUT002 L-EDEWBODY 2 1 NONE TYPEBOUT003 L-EDEWBODY 3 1 NONE TYPEBOUT004 L-EDEWBODY 4 1 NONE TYPEBOUT005 L-EDEWBODY 5 1 NONE TYPEBOUT006 L-EDEWBODY 6 1 NONE TYPEBOUT007 L-EDEWBODY 7 1 NONE TYPEBOUT008 L-EDEWBODY 8 1 NONE TYPEBOUT009 L-EDEWBODY 9 1 NONE TYPEBOUT010 L-EDEWBODY 10 1 NONE TYPEBOUT011 L-EDEWBODY 1 9 NONE TYPEBOUT012 L-EDEWBODY 2 9 NONE TYPEBOUT013 L-EDEWBODY 3 9 NONE TYPEBOUT014 L-EDEWBODY 4 9 NONE TYPEBOUT015 L-EDEWBODY 5 9 NONE TYPEBOUT016 L-EDEWBODY 6 9 NONE TYPEBOUT017 L-EDEWBODY 7 9 NONE TYPEBOUT018 L-EDEWBODY 8 9 NONE TYPEBOUT019 L-EDEWBODY 9 9 NONE TYPEBOUT020 L-EDEWBODY 10 9 NONE
  • NUMC=0 TYPECNUMBER 0
  • NUMD = 0 TYPEDNUMBER 0

NIA-089

  • DOSMOD, dose model, LNT, AT or PL LCDOSMOD001 LNT
  • KIMODL, KI model EZKIMODL001 NOKI
  • EFFACY, KI Ingestion EZEFFACY001 0.
  • POPFRAC, KI Ingestion EZPOPFRC001 0.

.

Retrieved from "https://kanterella.com/w/index.php?title=ML11229A081&oldid=2548017"